The proposed project is a five year mentored training experience designed to prepare the applicant for a career in clinically-related basic science research. The candidate has an M.D. and Ph.D. and has research experience in mouse and human studies. The applicant is board-certified in pediatrics and medical genetics and is an Assistant Professor in the Department of Molecular and Human Genetics at Baylor College of Medicine (BCM). The Department of Molecular and Human Genetics at BCM has a long track record of training highly successful translational researchers, and BCM provides a world-class clinical and research training environment. The mentor is a leading expert in the field of inborn errors of metabolism and urea cycle disorders. The advisory committee was selected to complement the mentor's expertise and to provide valuable research and career guidance for the applicant. The career development plan includes participation in seminars, journal clubs, lab meetings, courses, national conferences, career development coursework, monthly mentor meetings, and advisory committee meetings. This research application investigates the etiology of reduced respiratory capacity which has recently been discovered in fibroblasts deficient in argininosuccinate lyase (ASL). Urea cycle disorders, such as argininosuccinate lyase deficiency (ASLD), are among the most common inborn errors of liver metabolism. With early diagnosis and treatment, patients with ASLD are surviving into adulthood but with long-term complications. As a result, new strategies for managing these complications, such as liver dysfunction, must be developed. Because many long-term complications are independent of hyperammonemia, other metabolic mechanisms must explain them. Given that ASL links the urea cycle and citric acid cycle (CAC) and has a structural role in channeling arginine for nitric oxide (NO) production, CAC dysfunction or NO deficiency may explain the energy dysfunction in this disorder. Studies in human and mouse fibroblasts will test whether this energy dysfunction is secondary to electron transport chain or CAC dysfunction and whether this energy dysfunction is due to the structural role of ASL in NO production or to the enzymatic role of ASL in fumarate and arginine production. Because mitochondrial abnormalities are observed in the liver of ASL-deficient humans and mice, energy dysfunction is hypothesized to contribute to this phenotype. ASL-deficient mice will be treated with sodium nitrite or citrate to test whether supplementation with NO or a CAC intermediate will result in improvement in hepatic dysfunction. In addition, this application will leverage an existing human clinical trial investigating whether NO supplementation improves vascular reactivity and neurocognitive function in patients with ASLD to test whether NO supplementation results in improvement in markers of liver dysfunction. This application, which provides a broad research experience in cell studies together with mouse and human studies, and the proposed career development plan will prepare this applicant for a career as an independent research scientist investigating inborn errors of liver metabolism.

Public Health Relevance

Urea cycle disorders, such as argininosuccinate lyase deficiency, are disorders of amino acid metabolism. The proposed project will investigate energy metabolism in this disorder and will test whether supplements that target energy metabolism (e.g. nitric oxide and citrate) will result in improvement in liver dysfunction, one long- term complication of this disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK106453-02
Application #
9143759
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK-B)
Program Officer
Spain, Lisa M
Project Start
2015-09-15
Project End
2019-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
2
Fiscal Year
2016
Total Cost
$148,266
Indirect Cost
$10,927
Name
Baylor College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Marom, Ronit; Jain, Mahim; Burrage, Lindsay C et al. (2017) Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability. Hum Mutat 38:1365-1371
Machol, Keren; Jain, Mahim; Almannai, Mohammed et al. (2017) Corner fracture type spondylometaphyseal dysplasia: Overlap with type II collagenopathies. Am J Med Genet A 173:733-739
Santiago-Sim, Teresa; Burrage, Lindsay C; Ebstein, Frédéric et al. (2017) Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features. Am J Hum Genet 100:676-688
Abbott, Megan; Jain, Mahim; Pferdehirt, Rachel et al. (2017) Neonatal fractures as a presenting feature of LMOD3-associated congenital myopathy. Am J Med Genet A 173:2789-2794
Almannai, Mohammed; Marom, Ronit; Divin, Kristian et al. (2017) Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. Mol Genet Metab 122:60-66
Burrage, Lindsay C; Guillerman, R Paul; Das, Shailendra et al. (2017) Lung Transplantation for FLNA-Associated Progressive Lung Disease. J Pediatr 186:118-123.e6
Atwal, Paldeep S; Medina, Casey R; Burrage, Lindsay C et al. (2016) Nineteen-year follow-up of a patient with severe glutathione synthetase deficiency. J Hum Genet 61:669-72